Free Trial

Celcuity (CELC) Insider Trading & Ownership

Celcuity logo
$12.63 -0.15 (-1.17%)
(As of 11:27 AM ET)

Celcuity (NASDAQ:CELC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
15.78%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$132,225.10
Get CELC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Celcuity stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CELC Insider Buying and Selling by Quarter

Celcuity Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/23/2024Richard E BullerDirectorSell350$16.25$5,687.50  
6/21/2024Richard E BullerDirectorSell350$15.68$5,488.00  
4/24/2024Richard E BullerDirectorSell350$17.06$5,971.00  
2/21/2024Richard E BullerDirectorSell350$14.15$4,952.50  
12/20/2023Richard E BullerDirectorSell350$14.37$5,029.50  
12/12/2023David DalveyDirectorSell2,060$14.61$30,096.60  
12/8/2023David DalveyDirectorSell5,000$15.00$75,000.00  
(Data available from 1/1/2013 forward)

CELC Insider Trading Activity - Frequently Asked Questions

The list of insiders at Celcuity includes Brian F Sullivan, David Dalvey, Richard E Buller, and Richard Nigon. Learn more on insiders at CELC.

15.78% of Celcuity stock is owned by insiders. Learn more on CELC's insider holdings.

The following insider purchased CELC shares in the last 24 months: Brian F Sullivan ($1,499,996.75).

Insiders have purchased a total of 260,869 CELC shares in the last 24 months for a total of $1,499,996.75 bought.

The following insiders have sold CELC shares in the last 24 months: David Dalvey ($105,096.60), and Richard E Buller ($50,195.50).

Insiders have sold a total of 11,060 Celcuity shares in the last 24 months for a total of $155,292.10 sold.

Celcuity Key Executives

  • Mr. Brian F. Sullivan (Age 62)
    Co-Founder, Chairman & CEO
    Compensation: $478.12k
  • Dr. Lance G. Laing Ph.D. (Age 62)
    Co-Founder, Chief Science Officer, VP, Secretary & Director
    Compensation: $389.55k
  • Ms. Vicky Hahne (Age 58)
    Chief Financial Officer
    Compensation: $281.59k
  • Dr. John R. MacDonald Dabt (Age 69)
    Ph., Ph.D., Senior Vice President of R&D
  • Ms. Sheri Smith
    Acting Head of Clinical Operations
  • Mr. Igor Gorbatchevsky M.D.
    Chief Medical Officer
  • Mr. Eldon C. Mayer III (Age 63)
    M.B.A., Chief Commercial Officer


This page (NASDAQ:CELC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners